These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35900928)

  • 21. Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
    Nayagam S; de Villiers MJ; Shimakawa Y; Lemoine M; Thursz MR; Walsh N; Hallett TB
    Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):635-645. PubMed ID: 37150181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
    Khetsuriani N; Zaika O; Chitadze N; Slobodianyk L; Allahverdiyeva V; O'Connor P; Huseynov S
    Vaccine; 2021 Mar; 39(10):1485-1492. PubMed ID: 33583671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Level of Hepatitis B Virus Infection in Children 20 Years After Initiation of Infant Vaccination Program in Wallis and Futuna.
    Pezzoli L; Mathelin JP; Hennessey K; Eswara-Aratchige P; Valiakolleri J; Kim SH
    Am J Trop Med Hyg; 2017 Mar; 96(3):715-719. PubMed ID: 28070010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W
    J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 May; 56(18):441-5. PubMed ID: 17495790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.
    Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Borkird T; Layangool P; Kamonpakorn N; Jitphiankha W; Kwanchaipanich R; Potchalongsin S; Lallemant M; Sirirungsi W; Goudeau A;
    J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
    Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
    Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.
    Al Awaidy ST; Ezzikouri S
    J Infect Public Health; 2020 Feb; 13(2):221-227. PubMed ID: 31445879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress towards the elimination of hepatitis B in children in Colombia: A novel two-phase study approach.
    Ríos-Hincapié CY; Murad-Rivera R; Tohme RA; Ropero AM; Gómez B; Librado Cardona D; Forest Duque BN; Cuellar D; Cardenas I; Krow-Lucal E; Wannemuehler K; de la Hoz Restrepo F; Sánchez-Molano SM; Delgado CE; Rivillas-Garcia JC; Wasley A
    J Viral Hepat; 2022 Sep; 29(9):737-747. PubMed ID: 35707957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
    Tamandjou Tchuem CR; Andersson MI; Wiysonge CS; Mufenda J; Preiser W; Cleary S
    Vaccine; 2021 May; 39(23):3141-3151. PubMed ID: 33962836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes and gaps of global and regional disease burden of hepatitis B infection in children younger than 5 years old between 2015 and 2019: A real-world data review.
    Wang C; Zhang S; Zhao J; Wang M; Lu QB; Liu B; Du J; Cui F
    J Med Virol; 2023 Nov; 95(11):e29241. PubMed ID: 38010806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B vaccine birthdose practices in a country where hepatitis B is endemic - Laos, December 2011-February 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jul; 62(29):587-90. PubMed ID: 23884345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus.
    Yang TU; Vargas-Zambrano JC; Park HA; Jung CW; Kim D; Jee Y
    Hum Vaccin Immunother; 2023 Dec; 19(3):2278940. PubMed ID: 37955105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
    Mao B; Patel MK; Hennessey K; Duncan RJ; Wannemuehler K; Soeung SC
    Vaccine; 2013 Sep; 31(40):4459-64. PubMed ID: 23684825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
    Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
    Petit D; Tevi-Benissan C; Woodring J; Hennessey K; Kahn AL
    Vaccine; 2017 Dec; 35(49 Pt B):6866-6871. PubMed ID: 29132994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.